To achieve capital growth through investing in high growth, development stage biotechnology companies.
Find out MoreInt.biotech. Share Price | |
---|---|
Price | 642.00 |
Bid | 638.00 |
Ask | 646.00 |
Change | 10.00 (1.58%) |
Volume | 26,918 |
Open | 636.00 |
High | 642.00 |
Low | 636.00 |
Prev. Close | 632.00 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 37.71m |
Market Capitalisation | £242.08m |
Market Size | 750 |
52 Week High | 704.00 |
52 Week High Date | 28-Feb-2024 |
52 Week Low | 548.00 |
52 Week Low Date | 27-Oct-2023 |
# Trades | 33 |
---|---|
Vol. Sold | 13,877 |
Sold Value | £78.23k |
Vol. Bought | 8,041 |
Bought Value | £38.48k |
PE Ratio | 38.23705 |
Earnings | 16.79 |
Dividend | 28.20 |
Yield | 4.393% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
03-May-24 | 16:05:48 | 639.288 | 500 | Sell* | 638.00 | 646.00 | 3,196 | O Ordinary |
03-May-24 | 16:05:02 | 644.31 | 350 | Buy* | 638.00 | 646.00 | 2,255 | O Ordinary |
03-May-24 | 15:26:53 | 642.353 | 2,976 | Sell* | 640.00 | 646.00 | 19.12k | O Ordinary |
03-May-24 | 15:23:01 | 642.353 | 1,410 | Sell* | 640.00 | 646.00 | 9,057 | O Ordinary |
03-May-24 | 14:41:38 | 640.319 | 950 | Buy* | 634.00 | 642.00 | 6,083 | O Ordinary |
03-May-24 | 13:54:28 | 639.899 | 93 | Buy* | 632.00 | 642.00 | 595.11 | O Ordinary |
03-May-24 | 13:47:47 | 640.00 | 150 | Buy* | 638.00 | 640.00 | 960.00 | A Automatic Execution |
03-May-24 | 13:47:41 | 640.00 | 600 | Buy* | 638.00 | 640.00 | 3,840 | A Automatic Execution |
03-May-24 | 13:47:10 | 636.00 | 150 | Buy* | 626.00 | 636.00 | 954.00 | A Automatic Execution |
03-May-24 | 13:47:09 | 636.00 | 600 | Buy* | 626.00 | 636.00 | 3,816 | A Automatic Execution |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
07-Nov-23 | 07-Nov-23 | Buy | Caroline Gulliver held the position of Independent Non-Executive Director at the time of this trade.Caroline Gulliver | 573.15 | GBX | 2,500 | 17,000 |
04-Aug-23 | 03-Aug-23 | Buy | Patrick Magee held the position of Independent Non-Executive Director at the time of this trade.Patrick Magee | 632.00 | GBX | 1,500 | 11,500 |
03-Aug-23 | 03-Aug-23 | Buy | Katherine Cornish-Bowden held the position of Senior Independent Director at the time of this trade.Katherine Cornish-Bowden | 633.18 | GBX | 1,500 | 12,500 |
11-May-22 | 11-May-22 | Buy | Patrick Maxwell held the position of Independent Non-Executive Director at the time of this trade.Patrick Maxwell | 589.35 | GBX | 3,725 | 3,725 |
01-Apr-22 | 01-Apr-22 | Buy | Patrick Magee held the position of Independent Non-Executive Director at the time of this trade.Patrick Magee | 633.00 | GBX | 2,500 | 10,000 |